HomeAI · summaries
Storia in 2 fonti
Zydus Lifesciences shares in focus as firm acquires US-based Assertio Holdings for $166 million
Zydus Lifesciences has successfully acquired US-based Assertio Holdings Inc. for $166.4 million in a cash tender offer. This strategic move, completed through its subsidiary Zara Merger Sub Inc., makes Assertio a wholly-owned subsidiary and strengthens Zydus's pipeline of innovative drugs, particularly in specialty and oncology supportive-care therapies.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Zydus Lifesciences completes acquisition of Assertio
The company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding shares of common stock of Assertio…
- ·
morningstar.com
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its…
